medicasolution

+2

The site is built around feature stories of elite and competitive athletes who use the company's products as part of their regimen. With contributors: Dr. David Pascal, Dr. Jerry Moylan, John Radich, Ben Greenfield, Judy Maguire. All established names in their fields.

Source link: 

http://naturalvitalitysports.com/

Spinal Muscular Atrophy is one of many serious disorders for which prenatal testing is available. SMA affects approximately 1 in 10,000 live births and is the leading genetic cause of infant mortality and the second most common autosomal recessive disorder, after cystic fibrosis. Although the American College of Medical Genetics recommends carrier testing for all couples, the American College of Obstetricians and Gynecologists has issued a recommendation to the contrary, citing lack of information about the costs and benefits of screening for SMA.

+2

He received a suspended six-year sentence, but the case will be expunged from his record if he successfully completes eight years of probation, officials said.

Source link: 

http://www.knoxnews.com/news/2010/mar/08/former-coach-admits-selling-ste...

YM BioSciences Inc., today announced that the previously announced offering of approximately US$15 million has been increased to approximately US$17.5 million.

+1

In the 75kg welterweight category, Jassim emerged champion after fierce competition with five of the world's best amateur bodybuilders.

Source link: 

http://bit.ly/9goRLk

The Journal of the American Academy of Dermatology (JAAD) has published Phase III data evaluating the safety and efficacy of imiquimod cream at two doses - 2.5% and 3.75% - administered daily on a 2-week treatment cycle. The study demonstrates that both formulations were superior to placebo, and that imiquimod 3.75% on a daily 2-week treatment cycle is superior to imiquimod 2.5% in treating actinic keratosis (AK) on a large surface area - the face or balding scalp.

The Journal of the American Academy of Dermatology has published Phase III data evaluating the safety and efficacy of imiquimod cream at two doses – 2.5% and 3.75% – administered daily on either 2-week or 3-week treatment cycles.

Molecular dermatology research and development innovator DermaGenoma, Inc. today released The HerpesDX Genetic Test for Frequent Genital Herpes. The new screening test will help doctors assess patients’ risk for developing frequent Genital Herpes (HSV-2) outbreaks.

Doctors treat millions of children with Ritalin every year to improve their ability to focus on tasks, but scientists now report that Ritalin also directly enhances the speed of learning.

0